Staying More Active During the Day Helps Retain Brain Volume
A new study suggests that how active you are during the day, not just how much you exercise, may play an important role in maintaining brain health as you age.
From Phase I to IV: Clinical Trials Explained
Before a medicine becomes available, it must pass through four phases of clinical trials. Each phase is designed to answer questions about safety, effectiveness, and proper use in patients.
Why Patient-Centred Care Matters and How Clinical Research Can Make It a Reality
Better care starts with listening and prioritising patients’ needs. Discover why patient-centred care matters and how clinical trials can help make it a reality.
Meningitis B: How Does it Spread and When Should You See a Doctor?
A recent outbreak of meningitis B in Kent has raised concerns due to how quickly cases have spread. The bacteria causing it are highly contagious and spread through close contact.
Clinical Trials Made Simple: What Patients Should Know
Do you have questions about clinical research or want to understand the terminology? This guide breaks down the most important concepts in a clear and patient friendly way.
Taking Part in a Clinical Trial: Alison’s Experience as a First Time Participant
How clear communication, flexibility, and ongoing support helped Alison feel informed, reassured and confident taking part in her first clinical trial.
We Are Proud to Collaborate with the Patients Association!
We are collaborating with The Patients Association, the UK’s leading independent patient charity. They work with patients to campaign for improvements in health and social care.
Listening to All Voices: What Patient Advocate Carole Scrafton Wants Researchers to Know
Patient advocate Carole has been motivated to support research from a young age. She reminds us that research is strongest when more voices are actively included throughout the process.
Largest Ever Parkinson’s Disease Trial Opens Across UK
The largest Parkinson’s disease clinical trial ever conducted has been launched in the UK, aiming to speed up the discovery of treatments that could slow or stop the progression of the condition.
2 New Subtypes of MS Found Aided by Artificial Intelligence
Two new biological subtypes of multiple sclerosis (MS) have been identified in research that could change how the disease is understood and treated.